ARTICLE | Top Story
Genentech ends an AERx program
February 5, 2001 8:00 AM UTC
DNA discontinued development of rhDNase recombinant deoxyribonuclease using Aradigm's AERx Pulmonary Drug Delivery System inhaler to treat cystic fibrosis. RhDNase is the active ingredient of DNA's ma...